He's using his talent to help others, and he's hoping you'll join him. "I'm principle trumpet of the Nashville Symphony," Will Leathers said. "I don't remember a day in my life that I didn't hear ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).